| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.19e-04 | 11 | 30 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.43e-04 | 12 | 30 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.96e-04 | 14 | 30 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.90e-04 | 465 | 30 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.05e-03 | 32 | 30 | 2 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.81e-03 | 42 | 30 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.23e-03 | 627 | 30 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.86e-03 | 664 | 30 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 4.41e-03 | 66 | 30 | 2 | GO:0005080 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.04e-03 | 758 | 30 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.09e-03 | 793 | 30 | 5 | GO:0015075 | |
| MousePheno | abnormal fear/anxiety-related behavior | 3.19e-05 | 919 | 21 | 8 | MP:0002065 | |
| MousePheno | abnormal synaptic transmission | 9.47e-05 | 1070 | 21 | 8 | MP:0003635 | |
| MousePheno | abnormal synaptic physiology | 9.86e-05 | 1076 | 21 | 8 | MP:0021009 | |
| Domain | ANK | 1.93e-10 | 251 | 31 | 9 | SM00248 | |
| Domain | ANK_REPEAT | 2.07e-10 | 253 | 31 | 9 | PS50088 | |
| Domain | ANK_REP_REGION | 2.14e-10 | 254 | 31 | 9 | PS50297 | |
| Domain | Ankyrin_rpt | 2.82e-10 | 262 | 31 | 9 | IPR002110 | |
| Domain | Ank | 2.70e-09 | 228 | 31 | 8 | PF00023 | |
| Domain | - | 5.23e-09 | 248 | 31 | 8 | 1.25.40.20 | |
| Domain | Ankyrin_rpt-contain_dom | 6.31e-09 | 254 | 31 | 8 | IPR020683 | |
| Domain | Ank_2 | 5.05e-08 | 215 | 31 | 7 | PF12796 | |
| Domain | TRP_dom | 3.98e-05 | 6 | 31 | 2 | IPR013555 | |
| Domain | TRP_2 | 3.98e-05 | 6 | 31 | 2 | PF08344 | |
| Domain | TRPC_channel | 5.57e-05 | 7 | 31 | 2 | IPR002153 | |
| Domain | TRP_channel | 1.45e-04 | 11 | 31 | 2 | IPR004729 | |
| Domain | Actin_CS | 3.15e-04 | 16 | 31 | 2 | IPR004001 | |
| Domain | ACTINS_2 | 3.57e-04 | 17 | 31 | 2 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.01e-04 | 18 | 31 | 2 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 4.48e-04 | 19 | 31 | 2 | PS01132 | |
| Domain | ACTIN | 1.20e-03 | 31 | 31 | 2 | SM00268 | |
| Domain | Actin | 1.20e-03 | 31 | 31 | 2 | IPR004000 | |
| Domain | Actin | 1.20e-03 | 31 | 31 | 2 | PF00022 | |
| Domain | Ion_trans_dom | 1.53e-02 | 114 | 31 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.53e-02 | 114 | 31 | 2 | PF00520 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 9.44e-05 | 10 | 21 | 2 | M27330 | |
| Pathway | WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS | 1.63e-04 | 13 | 21 | 2 | MM15819 | |
| Pathway | WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS | 1.90e-04 | 14 | 21 | 2 | M39614 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 2.19e-04 | 15 | 21 | 2 | M22002 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 2.84e-04 | 17 | 21 | 2 | MM15861 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 2.84e-04 | 17 | 21 | 2 | M39511 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.61e-04 | 681 | 21 | 6 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 5.48e-04 | 736 | 21 | 6 | M27287 | |
| Pathway | REACTOME_TRP_CHANNELS | 7.81e-04 | 28 | 21 | 2 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 7.81e-04 | 28 | 21 | 2 | M27241 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.93e-03 | 44 | 21 | 2 | M875 | |
| Pubmed | 2.06e-11 | 7 | 32 | 4 | 15276201 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 8.00e-10 | 15 | 32 | 4 | 16824795 | |
| Pubmed | 7.92e-09 | 163 | 32 | 6 | 24316575 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 17171436 | ||
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 12475935 | ||
| Pubmed | 5.92e-08 | 9 | 32 | 3 | 16364570 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 23677990 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34899056 | ||
| Pubmed | Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. | 8.20e-07 | 2 | 32 | 2 | 17593972 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 26317356 | ||
| Pubmed | Involvement of TRPC4 and 5 Channels in Persistent Firing in Hippocampal CA1 Pyramidal Cells. | 8.20e-07 | 2 | 32 | 2 | 32033274 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 8.20e-07 | 2 | 32 | 2 | 19669888 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 17624425 | ||
| Pubmed | A novel capacitative calcium entry channel expressed in excitable cells. | 8.20e-07 | 2 | 32 | 2 | 9687496 | |
| Pubmed | TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. | 8.20e-07 | 2 | 32 | 2 | 30038709 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 22457348 | ||
| Pubmed | Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels. | 2.46e-06 | 3 | 32 | 2 | 28325835 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 32359120 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 28790178 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 2.46e-06 | 3 | 32 | 2 | 17101985 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 34199280 | ||
| Pubmed | Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels. | 2.46e-06 | 3 | 32 | 2 | 30755645 | |
| Pubmed | Dual action of the Gαq-PLCβ-PI(4,5)P2 pathway on TRPC1/4 and TRPC1/5 heterotetramers. | 2.46e-06 | 3 | 32 | 2 | 30108272 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 23188715 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 18261457 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 20164195 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 17342726 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 32110987 | ||
| Pubmed | NMDA receptor-dependent synaptic activation of TRPC channels in olfactory bulb granule cells. | 4.92e-06 | 4 | 32 | 2 | 22539836 | |
| Pubmed | Enhanced capacitative calcium entry and TRPC channel gene expression in human LES smooth muscle. | 8.19e-06 | 5 | 32 | 2 | 12736151 | |
| Pubmed | Formation of novel TRPC channels by complex subunit interactions in embryonic brain. | 8.19e-06 | 5 | 32 | 2 | 12857742 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 10980202 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 20458742 | ||
| Pubmed | trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. | 1.23e-05 | 6 | 32 | 2 | 8646775 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 25347706 | ||
| Pubmed | TRPC channels regulate Ca2+-signaling and short-term plasticity of fast glutamatergic synapses. | 1.23e-05 | 6 | 32 | 2 | 31536487 | |
| Pubmed | Host airway proteins interact with Staphylococcus aureus during early pneumonia. | 1.23e-05 | 6 | 32 | 2 | 18195024 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 32414784 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 11390792 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 29373286 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 36476978 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 32350291 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 1.72e-05 | 7 | 32 | 2 | 15757897 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 38835669 | ||
| Pubmed | Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. | 1.72e-05 | 7 | 32 | 2 | 23233529 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 1.72e-05 | 7 | 32 | 2 | 15336983 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 36257322 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 2.29e-05 | 8 | 32 | 2 | 12032305 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 15199065 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 25471572 | ||
| Pubmed | Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. | 2.94e-05 | 9 | 32 | 2 | 14505576 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 17480026 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 11290752 | ||
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 3.67e-05 | 10 | 32 | 2 | 18989690 | |
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 27177420 | ||
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 22051675 | ||
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 22411552 | ||
| Pubmed | 1.70e-04 | 21 | 32 | 2 | 30270038 | ||
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 9722956 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 2.24e-04 | 24 | 32 | 2 | 33884443 | |
| Pubmed | 2.43e-04 | 25 | 32 | 2 | 16382100 | ||
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 23536097 | ||
| Pubmed | 3.49e-04 | 149 | 32 | 3 | 22664934 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 4.10e-04 | 697 | 32 | 5 | 28298427 | |
| Pubmed | 4.25e-04 | 33 | 32 | 2 | 19834762 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 5.65e-04 | 38 | 32 | 2 | 30786075 | |
| Pubmed | 7.57e-04 | 44 | 32 | 2 | 19322198 | ||
| Interaction | POTEC interactions | 7.83e-12 | 13 | 31 | 5 | int:POTEC | |
| Interaction | POTED interactions | 1.32e-08 | 4 | 31 | 3 | int:POTED | |
| Interaction | POTEB3 interactions | 2.32e-07 | 35 | 31 | 4 | int:POTEB3 | |
| Interaction | POTEG interactions | 7.18e-07 | 12 | 31 | 3 | int:POTEG | |
| Interaction | POTEF interactions | 2.37e-05 | 228 | 31 | 5 | int:POTEF | |
| Interaction | ZNF684 interactions | 1.77e-04 | 13 | 31 | 2 | int:ZNF684 | |
| Cytoband | 2q21.1 | 7.59e-04 | 58 | 32 | 2 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 5.00e-03 | 151 | 32 | 2 | chr2q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 5.26e-03 | 155 | 32 | 2 | chr1p32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q22 | 6.14e-03 | 168 | 32 | 2 | chr8q22 | |
| Cytoband | 14q11.2 | 7.02e-03 | 180 | 32 | 2 | 14q11.2 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 3.55e-15 | 13 | 23 | 6 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 1.44e-08 | 242 | 23 | 7 | 403 | |
| GeneFamily | Transient receptor potential cation channels | 5.73e-04 | 28 | 23 | 2 | 249 | |
| GeneFamily | Solute carriers | 1.33e-02 | 395 | 23 | 3 | 752 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 5.45e-06 | 584 | 32 | 7 | MM1080 | |
| ToppCell | mLN-(6)_Macrophage-(60)_Macrophage|mLN / shred on region, Cell_type, and subtype | 2.94e-07 | 199 | 32 | 5 | 1ea28b832c6173b1b58da432aaf21e6cd291561e | |
| ToppCell | mLN-Macrophage-Macrophage|mLN / Region, Cell class and subclass | 2.94e-07 | 199 | 32 | 5 | 6bbec8450afb30347b07da28401a698fc51a3c53 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.53e-06 | 182 | 32 | 4 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.71e-06 | 183 | 32 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.49e-06 | 187 | 32 | 4 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-06 | 188 | 32 | 4 | fcf1bebef7aa81b4a11c1f9e4319339c290ecd22 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 190 | 32 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 190 | 32 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | 3'_v3-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 1.03e-05 | 191 | 32 | 4 | 44a797b39254cbfa5c2bad8155436adfd3019bb0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 192 | 32 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-05 | 193 | 32 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.26e-05 | 63 | 32 | 3 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.68e-05 | 90 | 32 | 3 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.26e-04 | 136 | 32 | 3 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-04 | 136 | 32 | 3 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.65e-04 | 149 | 32 | 3 | 71d72a6e7b128ee96161e08f6a0d77be925e73a1 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 158 | 32 | 3 | ff9878fd768f22bf2ee4805bac2ba01cb3cb804a | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Platelets-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-04 | 158 | 32 | 3 | f2c39b2eff8f2728a9d482d88e0d04984306a3fd | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 158 | 32 | 3 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 158 | 32 | 3 | 2a222301474c4dfd9a776e197c10f4c1cacceb62 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-04 | 158 | 32 | 3 | fa9797a23254070c569fabe8a314b3e8b3ae9ebd | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 159 | 32 | 3 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-04 | 160 | 32 | 3 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 164 | 32 | 3 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | 22b31acbbef1936ce19b393cf880c63ea2fa0f1b | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.30e-04 | 167 | 32 | 3 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | facs-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | d2afc097ae1243574210be6a751685f949ea941a | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | c34c52165485f612add7a3e35a175d5a6e365e7c | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 170 | 32 | 3 | f3d5678669dcaed1836014cea543758b7ccc6b46 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 171 | 32 | 3 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-04 | 176 | 32 | 3 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | Hippocampus|World / BrainAtlas - Mouse McCarroll V32 | 2.69e-04 | 176 | 32 | 3 | f120a703f6d2f2d5f55eae1aea2e6382a485828f | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 177 | 32 | 3 | b326376e879afef579b1b7094d756aaff0de270b | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 177 | 32 | 3 | 393882f1bf7658a17e10a771b803339f16fb2e69 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 177 | 32 | 3 | 929cd8f530ce001623735da53b7278d02522e2b5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.78e-04 | 178 | 32 | 3 | fbf49766e1504df554856b84c0576c06f3167329 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 178 | 32 | 3 | a62137d7f5fac16619f8a02844cdb0be7a794bf2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | 820289f14ecf165758529c236bb220bb1a744f02 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | e5f781d35449628a7f356d71e26231dd63482eec | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-04 | 180 | 32 | 3 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.87e-04 | 180 | 32 | 3 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | 7a9aa96fb8035020640cc7d3df0c41c730516c6f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 182 | 32 | 3 | 1647367b75b4b107af06bb934394168230cfd7c2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 182 | 32 | 3 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-04 | 183 | 32 | 3 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-04 | 184 | 32 | 3 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | e502ec54971f518d0cf1b619b745607a8ab5ddf3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 185 | 32 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-04 | 186 | 32 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.26e-04 | 188 | 32 | 3 | 3e94d105ca96ceb5fdcca39a8050217913bc02da | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.26e-04 | 188 | 32 | 3 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-APOE+_Mac2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.31e-04 | 189 | 32 | 3 | e189ef6066f87177d758f0e3ed9a17e01031a391 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 191 | 32 | 3 | 87b974a320888d63aa8cefcd8dc97d525b56d848 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-04 | 193 | 32 | 3 | 9fd2bc726bddf414f3de1c7a5ffd9317d3c98e29 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 194 | 32 | 3 | 46e522ca59db545d1eb0c27cd4361f19d4f8f762 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-04 | 194 | 32 | 3 | ce0486ce43748ffe486f08fdddd1f6acbfcc6b0e | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-04 | 194 | 32 | 3 | 4f0fe237b326552dd1b018c58f0a26c365cfa6c5 | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 3.62e-04 | 195 | 32 | 3 | 72928a1d987a3a5361c666f3972292aefec5f548 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Microglia/Mac|metastatic_Brain / Location, Cell class and cell subclass | 3.62e-04 | 195 | 32 | 3 | ae48d493ebda5f87781181a3d1d73d8f84fc5e77 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-04 | 195 | 32 | 3 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-04 | 195 | 32 | 3 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 195 | 32 | 3 | b67d4f34cae729c18275486d3b20c9dd7d5cbe79 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 195 | 32 | 3 | 5a7c74f96f213c504abd65e751800da7e03e47d9 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 196 | 32 | 3 | 48f7516129570981846c667a07abe5a9abe62dcd | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.68e-04 | 196 | 32 | 3 | ef481eb306350311207f7a29fdfa1ae3feaba4d7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 196 | 32 | 3 | 97324c9e93f833e1f218e81fb53066d44c6892df | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 196 | 32 | 3 | 055993612af03bff5ef73580a6402578da850df9 | |
| ToppCell | Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.68e-04 | 196 | 32 | 3 | 861c402ed8b8fde3582cc777c1357b45f5a2489b | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.68e-04 | 196 | 32 | 3 | 88517bb92be2f05c1e1ad94af22ac10d8c5c13c7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-04 | 196 | 32 | 3 | ff88e5b919b1be93159ad2200a7786d1c5272724 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | 3.68e-04 | 196 | 32 | 3 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.73e-04 | 197 | 32 | 3 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 780ab4a9f1dbf1f58b70a716ba2949c4f51b9295 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.73e-04 | 197 | 32 | 3 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 3.73e-04 | 197 | 32 | 3 | d8dc65b580191827ab6bbad5e29f0089419ebaef | |
| ToppCell | LPS_anti-TNF|World / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 7768e613fa48a6ec4a3902559310b51345a7fe91 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 3.73e-04 | 197 | 32 | 3 | 3ad72b70406e8a4c6996ec41809b174a423dad38 | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.79e-04 | 198 | 32 | 3 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.79e-04 | 198 | 32 | 3 | d91bd26e499637949768587603cad3c03dcc56e7 | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 3.79e-04 | 198 | 32 | 3 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-04 | 198 | 32 | 3 | eb0a94c426a7c567f94490b848e28784587c6dcd | |
| ToppCell | NS-moderate-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.79e-04 | 198 | 32 | 3 | 1791f1b1195ac1735ca2c1e6adf04a7f39d63ac1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | a4543d636501a1b5b46c14a661ce9d169947c82c | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.79e-04 | 198 | 32 | 3 | f5a12861e2b8ff8309f3e4d0ad83d4f6860cc616 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 3.79e-04 | 198 | 32 | 3 | 6b956073898192b1c6c8da66416b6a9b20d28a82 | |
| ToppCell | 18-Airway-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 3.79e-04 | 198 | 32 | 3 | be200dc5b9d95c2d37998b29c59418f0ba68d2bb | |
| Disease | nicotine dependence (implicated_via_orthology) | 4.52e-05 | 12 | 25 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.84e-04 | 152 | 25 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 4.21e-04 | 774 | 25 | 5 | C0023893 | |
| Disease | Schizophrenia | 7.66e-04 | 883 | 25 | 5 | C0036341 | |
| Disease | cocaine dependence | 1.11e-03 | 58 | 25 | 2 | EFO_0002610 | |
| Disease | Alcohol abuse | 1.47e-03 | 67 | 25 | 2 | C0085762 | |
| Disease | longitudinal BMI measurement | 2.20e-03 | 82 | 25 | 2 | EFO_0005937 | |
| Disease | unipolar depression | 3.04e-03 | 1206 | 25 | 5 | EFO_0003761 | |
| Disease | upper face morphology measurement | 3.05e-03 | 97 | 25 | 2 | EFO_0010949 | |
| Disease | Visual seizure | 3.31e-03 | 101 | 25 | 2 | C0270824 | |
| Disease | Epileptic drop attack | 3.31e-03 | 101 | 25 | 2 | C0270846 | |
| Disease | Generalized seizures | 3.31e-03 | 101 | 25 | 2 | C0234533 | |
| Disease | Clonic Seizures | 3.31e-03 | 101 | 25 | 2 | C0234535 | |
| Disease | Vertiginous seizure | 3.31e-03 | 101 | 25 | 2 | C0422855 | |
| Disease | Gustatory seizure | 3.31e-03 | 101 | 25 | 2 | C0422854 | |
| Disease | Seizures, Somatosensory | 3.31e-03 | 101 | 25 | 2 | C0422850 | |
| Disease | Olfactory seizure | 3.31e-03 | 101 | 25 | 2 | C0422853 | |
| Disease | Seizures, Auditory | 3.31e-03 | 101 | 25 | 2 | C0422852 | |
| Disease | Generalized Absence Seizures | 3.31e-03 | 101 | 25 | 2 | C4505436 | |
| Disease | Convulsive Seizures | 3.31e-03 | 101 | 25 | 2 | C0751494 | |
| Disease | Seizures, Sensory | 3.31e-03 | 101 | 25 | 2 | C0751496 | |
| Disease | Atonic Absence Seizures | 3.31e-03 | 101 | 25 | 2 | C0751123 | |
| Disease | Complex partial seizures | 3.31e-03 | 101 | 25 | 2 | C0149958 | |
| Disease | Single Seizure | 3.31e-03 | 101 | 25 | 2 | C0751110 | |
| Disease | Epileptic Seizures | 3.31e-03 | 101 | 25 | 2 | C4317109 | |
| Disease | Jacksonian Seizure | 3.31e-03 | 101 | 25 | 2 | C0022333 | |
| Disease | Non-epileptic convulsion | 3.31e-03 | 101 | 25 | 2 | C0751056 | |
| Disease | Nonepileptic Seizures | 3.31e-03 | 101 | 25 | 2 | C3495874 | |
| Disease | Tonic Seizures | 3.37e-03 | 102 | 25 | 2 | C0270844 | |
| Disease | Absence Seizures | 3.37e-03 | 102 | 25 | 2 | C4316903 | |
| Disease | Convulsions | 3.37e-03 | 102 | 25 | 2 | C4048158 | |
| Disease | Seizures, Focal | 3.50e-03 | 104 | 25 | 2 | C0751495 | |
| Disease | Myoclonic Seizures | 3.50e-03 | 104 | 25 | 2 | C4317123 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IIPWNFPLVMLIWKI | 166 | P00352 | |
| ILEWILGKKDVMWIG | 236 | Q13510 | |
| WGLWLGCPLLVLMAK | 1136 | Q7RTW8 | |
| AAWWGKVPRKDLIVM | 146 | A5A3E0 | |
| LWMQKLAEWGPLARI | 401 | Q9HCP6 | |
| EEAPWLGWLLVKALM | 6 | Q92604 | |
| ILFLMPWVWGGVGTL | 46 | Q63HM2 | |
| KIIAAITLMGPQWWL | 771 | O60337 | |
| KPPLGLFLEWVMVAW | 541 | Q9P215 | |
| VGWGPITWLLMSEVL | 411 | Q9UGQ3 | |
| WWVIKGPVVGSIMVN | 306 | P41586 | |
| AAWWGKVPRKDLIVM | 146 | A0JP26 | |
| AAWWGKVPRKDLIVM | 146 | Q6S8J3 | |
| LLPKGWGMAFWIPFI | 621 | Q99575 | |
| MGLPQPGLWLKRLWV | 1 | P49895 | |
| WLIGFLISIPPMLGW | 161 | P08908 | |
| PKWILLDGDIDPMWI | 2221 | Q9NYC9 | |
| VWWIVHDGGMLMLLP | 851 | Q9H2X9 | |
| AAWWGKVPRKDLIVM | 146 | B2RU33 | |
| AAWWGKVPRKDLIVM | 146 | Q86YR6 | |
| LKLWEIGKIIGGMWR | 91 | Q969G3 | |
| EWPLKFPWEFVRMGL | 481 | Q9BVQ7 | |
| PIWLWKLMVIVGASV | 46 | Q8NFB2 | |
| KSVLWWGGVLLMAVG | 86 | Q9H841 | |
| WKPMWVVLLEDGIEF | 21 | P08567 | |
| GLMQWIIRKVGWIML | 306 | Q9HAS3 | |
| MWGFLVLKARWLVTP | 1 | Q7Z2R9 | |
| EMLIGPQLDEKRWGW | 6 | Q8WTU2 | |
| TVVEWMILPWVLGFI | 401 | Q9UL62 | |
| MILPWVLGFIWGEIK | 406 | Q9UL62 | |
| AAWWGKVPRKDLIVM | 146 | Q6S5H5 | |
| AAWWGKVPRKDLIVM | 146 | A6NI47 | |
| PKGVEWLWHSIVIRM | 671 | Q99959 | |
| ILPWVLGFIWGEIKQ | 406 | Q9UBN4 |